Bloating News and Research

RSS

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).

14 Sep 2009

COCA to conduct meeting on ovarian cancer awareness

The Colorado Ovarian Cancer Alliance (COCA) “March on the Capitol,” on Friday, Sept. 4, noon, features speakers Lt. Gov. Barbara O’Brien, Congresswoman Diana DeGette and Dr. Daniel Donato, gynecological oncologist, Rocky Mountain Cancer Centers.

1 Sep 2009

More than half of women with ovarian cancer face delay in diagnosis

Many women with ovarian cancer can go undiagnosed for months because their symptoms are not always being investigated promptly, warn researchers at the University of Bristol in a study published on bmj.com today.

26 Aug 2009

Low-dose estrogen effective for metastatic breast cancer

When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.

19 Aug 2009

Canadian experts on irritable bowel syndrome

While more than six per cent of Canadians suffer from this troublesome disease - characterized by on-going abdominal pain, discomfort, bloating, and severe bouts of either diarrhoea or constipation - most Canadians, including many physicians, know little about it.

16 Apr 2009

Vaccine for Coeliac disease could mean the end of gluten free diets

Australian scientists have developed an experimental vaccine to treat coeliac disease. The team at the Walter and Eliza Hall (WEHI) Institute in Melbourne are hoping a phase 1 clinical trial of the vaccine, due to begin this month, will eventually lead to an effective clinical treatment for the disease.

15 Apr 2009

Novel assays provide new insight into why patients are in heart failure

A failing heart makes a lot of a hormone needed to eliminate the excess salt and water bloating the body but not enough of the enzyme needed to activate it, researchers say.

1 Apr 2009

Review of probiotics in the treatment of Irritable Bowel Syndrome

A review by researchers at Northwestern University (Chicago, IL.) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS, including abdominal pain, bloating and bowel movement difficulty.

23 Mar 2009

New treatment target for chronic abdominal pain

High levels of a protein linked to the way pain signals are sent to the brain led to a decrease in abdominal pain in a recent study in mice.

2 Mar 2009

Nothing silent about the way ovarian cancer kills

A new study by Australian scientists has revealed that far from being a silent killer, most women diagnosed with ovarian cancer had one or two unusual and persistent symptoms before they were diagnosed.

3 Feb 2009

Updated guidelines for irritable bowel syndrome

Although irritable bowel syndrome (IBS) is the most common disease diagnosed by gastroenterologists, it's also one of the most misunderstood.

18 Dec 2008

Women mostly satisfied with egg donation; some claim problems

Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.

17 Dec 2008

10 symptoms that should never be ignored

Not every ache and pain merits a quick trip to the doctor -- but some do.

6 Nov 2008

Risk of sudden cardiac death highest early after attack

People who survive a heart attack face the greatest risk of dying from sudden cardiac death (SCD) during the first month after leaving the hospital, according to a long-term community study by Mayo Clinic researchers of nearly 3,000 heart attack survivors.

5 Nov 2008

Heart attack survivors at highest risk of dying in the month after leaving hospital

According to researchers in the U.S. survivors of heart attacks face the greatest risk of dying from sudden cardiac death during the first month after leaving the hospital.

5 Nov 2008

Colonoscopy prep harder on women than men

Colonoscopy is especially important for women, because they're more likely to have polyps or lesions deeper in the colon. Only colonoscopy examines the entire length of the colon. Emptying the contents of the colon - a step called bowel prep - is essential to a successful colonoscopy. But there's some reason to believe that bowel prep for a colonoscopy is harder for women than for men, reports the November 2008 issue of Harvard Women's Health Watch.

27 Oct 2008

Too many women ignorant of symptoms of ovarian cancer

A new survey had revealed that though ovarian cancer remains one of biggest gynaecological cancer killers, many women are unsure or unaware of the symptoms of the disease.

10 Aug 2008

Clomifene citrate or unstimulated intrauterine insemination do not seem to improve fertility

Long established medical interventions to help couples with infertility problems do not seem to improve fertility, according to a study published on bmj.com.

10 Aug 2008

Symptom screening plus a simple blood test equals a 20 percent jump in early detection of ovarian cancer

Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.

1 Jul 2008